-
Dr Klempner Highlights Practice-Changing Role of Durvalumab/FLOT in Gastric Cancer
03 Jul 2025 18:21 GMT
… implications for oncologists managing resectable gastric cancers?
There are a few. First …
-
[Contribution] Tailored lymph node dissection is reshaping stomach cancer surgery
03 Jul 2025 06:58 GMT
… Kyo-young
Surgery for stomach cancer involves three main techniques … stage stomach cancer as well as in more advanced stomach cancer, … node dissection in advanced gastric cancer and selective lymph … early gastric cancer.
It means that for early-stage stomach cancer, …
-
Diddy Sued For $10 Million, Male Dancer Claims He Caught STD, Stomach Cancer
03 Jul 2025 05:17 GMT
… a sexually transmitted disease and stomach cancer.
The plaintiff, Edmond Laurent, filed … , including but not limited to stomach cancer,” the lawsuit states.
The complaint …
-
Kiran Turaga-led team develops new national guidelines for stomach cancers
02 Jul 2025 21:29 GMT
A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for peritoneal surface malignancies (PSMs) or cancers in the lining of the abdominal cavity.
The new consensus guidelines developed by …
-
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Preclinical Data Supporting TNX-1700 As Immunotherapy Enhancer In Gastric Cancer
02 Jul 2025 20:02 GMT
… metastases in mouse models of gastric cancer. Developed in collaboration with Columbia …
-
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
02 Jul 2025 15:15 GMT
… treatment options for gastric cancers continue to be … in 1L Gastric Cancers 17 advanced metastatic gastric cancer patients … 18.2-positive gastric cancers. Givastomig conditionally activates … first-line metastatic gastric cancers, with additional potential …
-
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
02 Jul 2025 11:00 GMT
… in the treatment of gastric cancer and other tumors.” … elevated PMN-MDSCs in gastric cancer patients, highlighting the … the tumor microenvironment. In gastric cancer, TFF2 is epigenetically silenced … , he showed in gastric cancer models that suppressing MDSCs …
-
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
02 Jul 2025 10:00 GMT
… Hopkins Researchers Say Yes
Gastric cancer is the fifth leading … .
“Most patients with gastric cancer are diagnosed at an … effective targeted therapy for gastric cancer.”
The most common treatment … patients with first-line gastric cancer, with a data readout …
-
Amgen announces phase 3 FORTITUDE─101 trial of bemarituzumab plus chemotherapy (mFOLFOX6) to treat first line gastric cancer meets its primary endpoint
02 Jul 2025 07:23 GMT
… immunohistochemistry (IHC) testing.
Gastric cancer is the fifth leading cause … "Most patients with gastric cancer are diagnosed at an … effective targeted therapy for gastric cancer."
The most … patients with first-line gastric cancer, with a data …
-
Amgen's Five Prime takeover delivers gastric cancer win
01 Jul 2025 19:47 GMT
… FGFR2b-positive advanced gastric cancer, and has revealed … is particularly prominent in gastric cancer and gastroesophageal junction ( … quot;Most patients with gastric cancer are diagnosed at … therapy for gastric cancer," he added.
Gastric cancer is the …
About
© 1995-2025